Immorna Biotherapeutics, Inc.
Registry sponsor category
Industry
- Other names
- Immorna Biotherapeutics, Inc.
- Company name
- Immorna Biotherapeutics, Inc.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (7)
- A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
- A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine
- A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
- A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
- One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors
- Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
- Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors